Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Pregnancy does not increase melanoma recurrence risk

DiSano JA et al. J Surg Res. 2018 Jun 16. doi: 10.1016/j.jss.2018.05.026.

Key clinical point: Pregnancy after melanoma does not appear to increase risk for melanoma recurrence.

Major finding: The rate of pregnancy for women with melanoma was 15.8%, compared with 13.6% for controls (P less than .001).

Study details: A retrospective study of claims database records on 11,801 women with melanoma and an equal number of matched controls.

Disclosures: The study was supported by a Barsumian Trust grant; the authors reported having no conflicts of interest.

Read the article.

Citation:

DiSano JA et al. J Surg Res. 2018 Jun 16. doi: 10.1016/j.jss.2018.05.026.

This Week's Must Reads

Improved myeloma outcomes associated with having prescription drug coverage, Olszewski A et al. J Clin Oncol. 2018 Aug 16. doi: 10.1200/JCO.2018.77.8894

For lymphoma patients, insurance is a matter of life or death , Goldstein JS et al. Blood. 2018 Jul 24. doi: 10.1182/blood-2018-03-839035

Expansion in clinical trial eligibility requested by ASCO, Friends of Cancer and ASCO letter to the FDA

Promise of broad genomic testing of NSCLC disappoints in community oncology , Presley CJ et al. JAMA. 2018 Aug 7. doi: 10.1001/jama.2018.9824

Must Reads in Melanoma

Pregnancy does not increase melanoma recurrence risk, DiSano JA et al. J Surg Res. 2018 Jun 16. doi: 10.1016/j.jss.2018.05.026.

FDA Approves First Treatment for Rare Skin Cancer, FDA news release; 2017 Mar 23

High-Dose Interferon vs Observation for Melanoma , J Clin Oncol; ePub 2017 Jan 30; Agarwala, et al

Trends in US Melanoma Incidence and Mortality, JAMA Dermatol; ePub 2016 Dec 21; Glazer, et al

Ipilimumab’s Impact on Stage III Melanoma Evaluated , N Engl J Med; ePub 2016 Oct 8; Eggermont, et al